ZiYi Lim

1.2k total citations
28 papers, 784 citations indexed

About

ZiYi Lim is a scholar working on Hematology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, ZiYi Lim has authored 28 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 6 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in ZiYi Lim's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Chronic Myeloid Leukemia Treatments (6 papers). ZiYi Lim is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Chronic Myeloid Leukemia Treatments (6 papers). ZiYi Lim collaborates with scholars based in United Kingdom, United States and Singapore. ZiYi Lim's co-authors include Ghulam J. Mufti, Janet Hayden, Antonio Pagliuca, Aloysius Ho, Linda D. Barber, Katie Matthews, Shahram Kordasti, Giovanna Lombardi, Barbara‐ann Guinn and Farzin Farzaneh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

ZiYi Lim

28 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ZiYi Lim United Kingdom 10 633 194 181 158 144 28 784
Wolfram Pönisch Germany 15 806 1.3× 179 0.9× 218 1.2× 198 1.3× 220 1.5× 62 1.0k
Sabine Fürst France 16 589 0.9× 184 0.9× 177 1.0× 75 0.5× 141 1.0× 46 727
Seung‐Hwan Shin South Korea 18 570 0.9× 123 0.6× 133 0.7× 162 1.0× 169 1.2× 68 777
I M Franklin United Kingdom 17 466 0.7× 264 1.4× 133 0.7× 127 0.8× 171 1.2× 28 742
Kris Doney United States 14 756 1.2× 202 1.0× 275 1.5× 80 0.5× 158 1.1× 18 902
Simona Iacobelli Italy 14 637 1.0× 99 0.5× 204 1.1× 246 1.6× 118 0.8× 36 851
Ali Alahmari Saudi Arabia 15 456 0.7× 194 1.0× 108 0.6× 126 0.8× 177 1.2× 78 670
Jean Paul Vernant France 13 665 1.1× 120 0.6× 122 0.7× 148 0.9× 311 2.2× 25 863
Odile Beyne Rauzy France 9 450 0.7× 173 0.9× 78 0.4× 180 1.1× 95 0.7× 31 608
Martine Delain France 16 560 0.9× 134 0.7× 88 0.5× 211 1.3× 243 1.7× 35 893

Countries citing papers authored by ZiYi Lim

Since Specialization
Citations

This map shows the geographic impact of ZiYi Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ZiYi Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ZiYi Lim more than expected).

Fields of papers citing papers by ZiYi Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ZiYi Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ZiYi Lim. The network helps show where ZiYi Lim may publish in the future.

Co-authorship network of co-authors of ZiYi Lim

This figure shows the co-authorship network connecting the top 25 collaborators of ZiYi Lim. A scholar is included among the top collaborators of ZiYi Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ZiYi Lim. ZiYi Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Liyuan, Siguo Hao, Colin Phipps Diong, et al.. (2014). WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients. Annals of Hematology. 94(5). 761–769. 1 indexed citations
3.
Potter, Victoria, Pramila Krishnamurthy, Linda D. Barber, et al.. (2013). Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(1). 111–117. 18 indexed citations
4.
5.
Ramasamy, Karthik, ZiYi Lim, Stephen Devereux, et al.. (2011). Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia – A Single-Institution Experience. Clinical Lymphoma Myeloma & Leukemia. 11(2). 242–245. 3 indexed citations
6.
Moses, Samuel, ZiYi Lim, & Mark Zuckerman. (2011). Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients. Expert Review of Anti-infective Therapy. 9(10). 891–899. 9 indexed citations
7.
Jiang, Jie, Austin Kulasekararaj, Pramila Krishnamurthy, et al.. (2011). Telomere Length In MDS Patients Bone Marrow Is Highly Correlated with Complex Cytogenetics, IPSS Risk Groups and Transfusion Dependency,. Blood. 118(21). 3826–3826. 2 indexed citations
9.
Chen, Jing, et al.. (2010). Outcome of Chinese children with unrelated donor hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 55(7). 1386–1392. 2 indexed citations
10.
Smith, Alexander, Azim Mohamedali, Austin Kulasekararaj, et al.. (2010). Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood. 116(19). 3923–3932. 175 indexed citations
11.
Kordasti, Shahram, Behdad Afzali, ZiYi Lim, et al.. (2009). IL‐17‐producing CD4+T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. British Journal of Haematology. 145(1). 64–72. 159 indexed citations
12.
Lim, ZiYi, Ronald Brand, Rodrigo Martino, et al.. (2009). Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. Journal of Clinical Oncology. 28(3). 405–411. 198 indexed citations
13.
Ramasamy, Karthik, ZiYi Lim, Antonio Pagliuca, et al.. (2007). Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: Report of three cases and review of literature. Leukemia & lymphoma. 48(2). 290–294. 10 indexed citations
15.
Lim, ZiYi, Antonio Pagliuca, Simon Cottam, et al.. (2006). Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. British Journal of Haematology. 136(3). 448–450. 21 indexed citations
16.
Lim, ZiYi, Jim Wade, Aloysius Ho, et al.. (2006). Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation. Journal of Infection. 54(2). e83–e86. 13 indexed citations
17.
Lim, ZiYi, Ronald Brand, Anja van Biezen, et al.. (2006). Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myelodysplastic Syndromes 50 Years or Older. A Retrospective Survey from the EBMT.. Blood. 108(11). 520–520. 1 indexed citations
18.
Patel, Raj, et al.. (2005). Heparin‐induced skin necrosis. British Journal of Haematology. 129(6). 712–712. 5 indexed citations
19.
Lim, ZiYi, Sunil Gupta, J R Salisbury, et al.. (2005). T‐cell lymphoblastic lymphoma presenting as an intra‐muscular mass. British Journal of Haematology. 132(5). 537–537. 4 indexed citations
20.
Lim, ZiYi, Aloysius Ho, Michelle Kenyon, et al.. (2005). Reduced Intensity Conditioned Volunteer Unrelated Donor Transplants Using Alemtuzumab Are Safe and Effective in Older Patients with Myelodysplastic Syndromes.. Blood. 106(11). 444–444. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026